NDC11 72603011301
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 72603-0113-01 | 72603-0113 |
| 72603-0113-1 | 72603-0113 |
| 72603-113-01 | 72603-113 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clorazepate Dipotassium | CLORAZEPATE DIPOTASSIUM | NORTHSTAR RX LLC | fb5c9e98-02b2-4c36-b436-25b58fe3c7d5 | 2024-10-28 | Boxed warning, Warnings, Adverse reactions | 72603-113-01 72603-113 72603011301 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.